The oral tablet formulation was approved for adults with weakened immune systems who have not responded to other therapy.
|Slideshows|May 10, 2019
- Drug Topics May 2019
- Volume 163
- Issue 5
How to Prevent HIPAA Mistakes
Author(s)Keith Loria
Brian McCullough, PharmD, BCPS, of Husson University notes some common mistakes pharmacists make with patient privacy and offers some ways to fix them.
Advertisement
Articles in this issue
over 7 years ago
New Drug Review: Spravatoover 7 years ago
Study Finds a Lack of Deprescribing is Harmful and Expensiveover 7 years ago
Opinion: Staffing, Phone Lines, and Drive-Throughsover 7 years ago
Cybersecurity: Safeguarding Your Pharmacy from Hackersover 7 years ago
Three Red Flags in Pharmacy Cash Flowover 7 years ago
CBD Products: Confusion, Hype, and Hopeover 7 years ago
Cost Challenges Are Ongoing with Diabetes Drugsover 7 years ago
Avoiding Patient Privacy Misstepsover 7 years ago
Workflow Management Is Critical for Everyoneover 7 years ago
The Role of Data Mitigating Drug DiversionAdvertisement
Related to this article
Melissa McGivney, PharmD, FAPhA, FCCP, helps celebrate American Pharmacists Month and the innovation driving the profession forward amongst US communities.
Teva Pharmaceuticals’ new olanzapine option is the first once-monthly subcutaneous injectable on the market for schizophrenia.
The novel tool can be used to inform vaccine policy, monitor impact, and essentially strengthen overall surveillance.
Melissa McGivney, PharmD, FAPhA, FCCP, discusses her career journey from her local pharmacy to a national leadership role with the American Pharmacists Association.
Researchers evaluate peer-reviewed literature on interventions to improve vaccine uptake among thousands of US adults studied between 2010 and 2015.
Infectious disease readiness depends on rehearsed workflows, bidirectional public health communication, and rapid access to care.
Pharmacist pain clinics typically focus on comprehensive medication management involving the entire patient scenario.
Advertisement
Advertisement
Trending on Drug Topics
1
Serotype 34 Causes Pneumococcal Meningitis in Child With Cochlear Implants
2
FDA Approves Once-Monthly Olanzapine Injection for Adults with Schizophrenia
3
American Pharmacists Month: The Many Career Paths US Pharmacists Explore
4
FDA Approves New Drug for HSV Lesions in Adults
5